Arévalo-Genicio, A.; GarcÃa-Arqué, M.C.; Gragea-Nocete, M.; Llistosella, M.; Moro-Casasola, V.; Pérez-DÃaz, C.; PuigdellÃvol-Sánchez, A.; Roca-Puig, R.
Long COVID Syndrome Prevalence in 2025 in an Integral Healthcare Consortium in the Metropolitan Area of Barcelona: Persistent and Transient Symptoms. Vaccines 2025, 13, 905.
https://doi.org/10.3390/vaccines13090905
AMA Style
Arévalo-Genicio A, GarcÃa-Arqué MC, Gragea-Nocete M, Llistosella M, Moro-Casasola V, Pérez-DÃaz C, PuigdellÃvol-Sánchez A, Roca-Puig R.
Long COVID Syndrome Prevalence in 2025 in an Integral Healthcare Consortium in the Metropolitan Area of Barcelona: Persistent and Transient Symptoms. Vaccines. 2025; 13(9):905.
https://doi.org/10.3390/vaccines13090905
Chicago/Turabian Style
Arévalo-Genicio, Antonio, Mª Carmen GarcÃa-Arqué, Marta Gragea-Nocete, Maria Llistosella, Vanessa Moro-Casasola, Cristina Pérez-DÃaz, Anna PuigdellÃvol-Sánchez, and Ramon Roca-Puig.
2025. "Long COVID Syndrome Prevalence in 2025 in an Integral Healthcare Consortium in the Metropolitan Area of Barcelona: Persistent and Transient Symptoms" Vaccines 13, no. 9: 905.
https://doi.org/10.3390/vaccines13090905
APA Style
Arévalo-Genicio, A., GarcÃa-Arqué, M. C., Gragea-Nocete, M., Llistosella, M., Moro-Casasola, V., Pérez-DÃaz, C., PuigdellÃvol-Sánchez, A., & Roca-Puig, R.
(2025). Long COVID Syndrome Prevalence in 2025 in an Integral Healthcare Consortium in the Metropolitan Area of Barcelona: Persistent and Transient Symptoms. Vaccines, 13(9), 905.
https://doi.org/10.3390/vaccines13090905
